Essential medicines and health products

Measuring Transparency in Medicines Registration, Selection and Procurement

Four Country Assessment Studies

Measuring transparency  to improve good governance in the public pharmaceutical sector

Publication details

Number of pages: 43
Publication date: March 2006
Languages: English
WHO reference number: WHO/PSM/PAR/2006.7

Despite revolutionary scientific progress and the sustained efforts of the development community, access to good quality essential medicines remains very limited in many parts of the world. This health crisis has many complex causes, including poverty, under‐investment in health systems and war. Corruption is another cause currently gaining increasing attention, as growing numbers of public health officials in ministries of health and national medicines regulatory authorities are recognizing the need for their institutions and personnel to work in a transparent and accountable environment.